Russell J. Schilder, MD, discusses new therapeutics and their role in gynecologic cancers.
Russell J. Schilder, MD
Advertisement
Articles by Russell J. Schilder, MD
Russell J. Schilder, MD, discusses the GOG-9929 trial.
Advertisement
Latest Updated Articles
An Analysis of the GOG-9929 TrialPublished: October 15th 2013 | Updated:
New Therapeutics in Gynecologic CancerPublished: October 28th 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
